| CYCLACEL PHARMA | (NSDQ: CYCC) |
|
|
|||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||
|
|
|
| Tue, May 21, 2013 | ||
|
Cyclacel Pharmaceuticals Announces Closing of Underwritten Offering - GlobeNewswire | |
| Fri, May 17, 2013 | ||
|
|
Free Research Reports on AMD, CYCC, GNK and KSS Issued by the Bedford Report - Marketwired | |
| Thu, May 16, 2013 | ||
|
|
Cyclacel Pharmaceuticals Announces $20 Million Underwritten Offering - GlobeNewswire | |
| Wed, May 15, 2013 | ||
|
|
Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock - GlobeNewswire | |
| Mon, May 13, 2013 | ||
|
|
Cyclacel Reports First Quarter 2013 Financial Results - GlobeNewswire | |
| More Press Releases | ||
|
|
